4MVN image
Entry Detail
PDB ID:
4MVN
Title:
Crystal structure of the staphylococcal serine protease SplA in complex with a specific phosphonate inhibitor
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2013-09-24
Release Date:
2014-01-22
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.20
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Serine protease splA
Chain IDs:A, B, C, D
Chain Length:200
Number of Molecules:4
Biological Source:Staphylococcus aureus
Ligand Molecules
Primary Citation
Development and binding characteristics of phosphonate inhibitors of SplA protease from Staphylococcus aureus.
Protein Sci. 23 179 189 (2014)
PMID: 24375505 DOI: 10.1002/pro.2403

Abstact

Staphylococcus aureus is responsible for a variety of human infections, including life-threatening, systemic conditions. Secreted proteome, including a range of proteases, constitutes the major virulence factor of the bacterium. However, the functions of individual enzymes, in particular SplA protease, remain poorly characterized. Here, we report development of specific inhibitors of SplA protease. The design, synthesis, and activity of a series of α-aminoalkylphosphonate diaryl esters and their peptidyl derivatives are described. Potent inhibitors of SplA are reported, which may facilitate future investigation of physiological function of the protease. The binding modes of the high-affinity compounds Cbz-Phe(P) -(OC6 H4 -4-SO2 CH3)2 and Suc-Val-Pro-Phe(P) -(OC6 H5)2 are revealed by high-resolution crystal structures of complexes with the protease. Surprisingly, the binding mode of both compounds deviates from previously characterized canonical interaction of α-aminoalkylphosphonate peptidyl derivatives and family S1 serine proteases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures